Reported studies have shown increased expression of XPO1 in various types of cancer, including pancreatic, ovarian, glioma, lung, gastric, prostate, liver, cervical, multiple myeloid, leukemia, and colorectal cancers. This evidence concerns the gene XPO1 and leukemia.